NCT00483366 2024-09-23
Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors
University of Nebraska
Phase 1 Completed
Clinical Trials
3 trialsNCT00253565 2013-04-08
Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors
Duke University
Phase 1 Completed
NCT00084513 2010-02-12
Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer
Fox Chase Cancer Center
Phase 1 Completed